Enhanced Oral Bioavailability of Paclitaxel by Coadministration of the P-Glycoprotein Inhibitor KR30031

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Pharmaceutical Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1023/A:1022286422439PMID 12608532
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 mice

  2004influential reference
• Active secretion and enterocytic drug metabolism barriers to drug absorption.

  2001cited by this paper
• Taxol transport by human intestinal epithelial Caco-2 cells.

  1998influential reference
• Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine.

  1997cited by this paper
• Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833.

  1997cited by this paper
• Structure-activity relationships for xenobiotic transport substrates and inhibitory ligands of P-glycoprotein.

  1997cited by this paper
• Novel multidrug-resistance modulators, KR-30026 and KR-30031, in cancer cells.

  1997cited by this paper
• Intestinal drug metabolism and antitransport processes : A potential paradigm shift in oral drug delivery

  1996cited by this paper
• Method, compositions and kits to increase the oral bioavailability of pharmaceutical agents.

  1996cited by this paper
• Differentiation of absorption and first‐pass gut and hepatic metabolism in humans: Studies with cyclosporine

  1995cited by this paper
• Taxol®: science and applications.

  1995cited by this paper
• The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine

  1995cited by this paper
• Clinical studies with modulators of multidrug resistance.

  1995cited by this paper
• Clinical Pharmacokinetics of Paclitaxel

  1994cited by this paper
• Effect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.

  1994cited by this paper
• Clinical toxicities encountered with paclitaxel (Taxol).

  1993cited by this paper
• Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport.

  1993influential reference
• Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity.

  1992cited by this paper
• Hypersensitivity reactions from taxol.

  1990cited by this paper
• Taxol metabolism. Isolation and identification of three major metabolites of taxol in rat bile.

  1990influential reference
• Reversal of multidrug resistance by lipophilic drugs.

  1990cited by this paper
• Clinical trials of agents that reverse multidrug-resistance.

  1989cited by this paper
• Effect of Caffeine on Ceftriaxone Disposition-(Physiological PharmacokineticModel of Ceftriaxone and Tenoxicam) : 권광일

  1987cited by this paper
• Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients.

  1987cited by this paper

• Competition for microtubule lattice spacing between a microtubule expander and compactor

  2025cites this paper
• Advanced oral drug delivery systems: Current challenges and emerging technologies

  2025cites this paper
• Impact of low BMI and ABCC2 genotype on the clinical response of sequential anthracycline-taxane chemotherapy receiving breast cancer patients: a hospital-based study

  2025cites this paper
• Solubilization of Paclitaxel with Natural Compound Rubusoside toward Improving Oral Bioavailability in a Rodent Model

  2024cites this paper
• Strategies to enhance the response of liver cancer to pharmacological treatments.

  2024cites this paper
• Chemotherapeutic properties and side-effects associated with the clinical practice of terpene alkaloids: paclitaxel, docetaxel, and cabazitaxel

  2023cites this paper
• Evaluating physiochemical properties of FDA-approved orally administered drugs

  2023cites this paper
• Redox-responsive drug-inhibitor conjugate encapsulated in DSPE-PEG2k micelles for overcoming multidrug resistance to chemotherapy.

  2023cites this paper
• Andrographolide liquisolid using porous-starch as the adsorbent with enhanced oral bioavailability in rats.

  2022cites this paper
• Evaluation of phytoconstituents of Tinospora cordifolia against K417N and N501Y mutant spike glycoprotein and main protease of SARS-CoV-2- an in silico study

  2022cites this paper
• P-glycoprotein Inhibition Exacerbates Paclitaxel Neurotoxicity in Neurons and Cancer Patients

  2021cites this paper
• Oral Site-Directed Drug Delivery and Influence on PK

  2021cites this paper
• Carbon nano-onion-mediated dual targeting of P-selectin and P-glycoprotein to overcome cancer drug resistance

  2021cites this paper
• Carbon nano-onion-mediated dual targeting of P-selectin and P-glycoprotein to overcome cancer drug resistance

  2021cites this paper
• P-glycoprotein Inhibition Exacerbates Paclitaxel Neurotoxicity in Neurons and Cancer Patients.

  2020cites this paper
• Acute regulation of apical ABC transporters in the gut. Potential influence on drug bioavailability.

  2020cites this paper
• Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment

  2020cites this paper
• Role for Drug Transporters in Chemotherapy‐Induced Peripheral Neuropathy

  2020cites this paper
• Liver and gastrointestinal cancers

  2020cites this paper
• Enhancing the Oral Bioavailability of Poorly Water Soluble BCS Class IV Drug Docetaxel Using Mesoporous Silica Nanoparticles

  2020cites this paper
• Zein-based micro- and nano-constructs and biologically therapeutic cues with multi-functionalities for oral drug delivery systems

  2020cites this paper
• Quantitative analysis of the effect of controlled-release formulation on nonlinear gastrointestinal absorption of P-glycoprotein substrate talinolol using physiologically based pharmacokinetic absorption model

  2020cites this paper
• Micro- and Nanofabrication of Polymeric Devices and Films for Oral Drug Delivery Applications

  2019cites this paper
• Effects of Piperazine Derivative on Paclitaxel Pharmacokinetics

  2019cites this paper
• Self-assembled micelles based on N-octyl-N'-phthalyl-O-phosphoryl chitosan derivative as an effective oral carrier of paclitaxel.

  2019cites this paper
• Reversal of P-Glycoprotein and Breast Cancer Resistance Protein Mediated Multidrug Resistance In Vitro Using In Silico Identified Novel Compounds

  2019cites this paper
• Intestinal P‐glycoprotein inhibitors, benzoxanthone analogues

  2018cites this paper
• 1, 3β-Glucan anchored, paclitaxel loaded chitosan nanocarrier endows enhanced hemocompatibility with efficient anti-glioblastoma stem cells therapy.

  2018cites this paper
• Optimization and Absorption Mechanism of DHP 107 , Oral Paclitaxel Formulation for Single-Agent Anticancer Therapy

  2018cites this paper
• Overcoming multiple drug resistance in cancer using polymeric micelles

  2018cites this paper
• RETRACTED ARTICLE: Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer

  2018cites this paper
• Enhanced oral bioavailability of docetaxel in rats combined with myricetin: In situ and in vivo evidences

  2017influential citation
• BCS class IV drugs: Highly notorious candidates for formulation development

  2017influential citation
• Pharmacokinetic and Pharmacodynamic Features of Nanoemulsion Following Oral, Intravenous, Topical and Nasal Route.

  2017cites this paper
• SELF-MICRO EMULSIFYING DRUG DELIVERY SYSTEMS (SMEDDS): A REVIEW ON PHYSICO-CHEMICAL AND BIOPHARMACEUTICAL ASPECTS

  2017cites this paper
• Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature Review

  2017cites this paper
• Interested in publishing with us ? Contact book

  2017cites this paper
• Therapeutic potential of taxanes in the treatment of metastatic pancreatic cancer

  2016cites this paper
• Effects of lipid vehicle and P-glycoprotein inhibition on the mesenteric lymphatic transport of paclitaxel in unconscious, lymph duct-cannulated rats

  2016cites this paper
• α-Tocopherols modify the membrane dipole potential leading to modulation of ligand binding by P-glycoprotein

  2015cites this paper
• Controlled Release, Intestinal Transport, and Oral Bioavailablity of Paclitaxel Can be Considerably Increased Using Suitably Tailored Pegylated Poly(Anhydride) Nanoparticles.

  2015cites this paper
• Preparation and In Vitro/In Vivo Evaluation of Puerarin Solid Self-Microemulsifying Drug Delivery System by Spherical Crystallization Technique

  2015cites this paper
• Xanthone analogues as potent modulators of intestinal P-glycoprotein.

  2015cites this paper
• Micro/nanofabricated platforms for oral drug delivery.

  2015cites this paper
• Investigating the role of Pluronic-g-Cationic polyelectrolyte as functional stabilizer for nanocrystals: Impact on Paclitaxel oral bioavailability and tumor growth.

  2015cites this paper
• PLASMA GLYCOPROTEIN INHIBITORS AS A NEW TARGET FOR OPTIMAL DRUG DELIVERY

  2015cites this paper
• Drug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and Challenges

  2015cites this paper
• Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy

  2015cites this paper
• Pharmacokinetic synergy from the taxane extract of Taxus chinensis improves the bioavailability of paclitaxel.

  2015cites this paper
• Development and validation of RP-HPLC method: scope of application in the determination of oil solubility of paclitaxel.

  2014cites this paper
• LIPID BASED DRUG DELIVERY SYSTEM FOR ENHANCING ORAL BIOAVAILABILITY – A CONTEMPORARY

  2014cites this paper
• Intestinal transporters: enhanced absorption through P-glycoprotein-related drug interactions

  2014cites this paper
• Paclitaxel formulations: challenges and novel delivery options.

  2014cites this paper
• Pharmacokinetic drug interactions between apigenin, rutin and paclitaxel mediated by P-glycoprotein in rats

  2014cites this paper
• Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake

  2014cites this paper
• Novel tablet formulation of amorphous candesartan cilexetil solid dispersions involving P-gp inhibition for optimal drug delivery: in vitro and in vivo evaluation

  2014cites this paper
• Stable phosphatidylcholine-bile salt mixed micelles enhance oral absorption of paclitaxel: preparation and mechanism in rats

  2014cites this paper
• Engineering erythrocytes as a novel carrier for the targeted delivery of the anticancer drug paclitaxel.

  2014cites this paper
• Expression of P-glycoprotein and CYP3A4 along the porcine oral-gastrointestinal tract: implications on oral mucosal drug delivery

  2014cites this paper
• P-glycoprotein Inhibition for Optimal Drug Delivery

  2013cites this paper
• Development of a self-microemulsifying drug delivery system to enhance oral bioavailability of β-elemene in rats

  2013cites this paper
• Extraction and RP-HPLC determination of taxol

  2013cites this paper
• Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS)

  2013cites this paper
• Extraction and RP-HPLC determination of taxol in rat plasma, cell culture and quality control samples

  2013cites this paper
• ABCG2: recent discovery of potent and highly selective inhibitors.

  2013cites this paper
• Polymers influencing transportability profile of drug.

  2013influential citation
• Comparative pharmacokinetics of paclitaxel after oral administration of Taxus yunnanensis extract and pure paclitaxel to rats.

  2013cites this paper
• Review Special Focu S: combating Re S i S tance: oncology

  2013cites this paper
• Oral delivery of anticancer drugs III: formulation using drug delivery systems.

  2013cites this paper
• Enhanced oral bioavailability and anti‐tumour effect of paclitaxel by 20(s)‐ginsenoside Rg3 in vivo

  2012cites this paper
• Interferon-alpha improves docetaxel antitumoral and antimetastatic efficiency in Lewis lung carcinoma bearing mice.

  2012cites this paper
• Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study.

  2012cites this paper
• Folic acid functionalized nanoparticles for enhanced oral drug delivery.

  2012cites this paper
• Effect of dose and dosage interval on the oral bioavailability of docetaxel in combination with a curcumin self-emulsifying drug delivery system (SEDDS)

  2012cites this paper
• Molecular buckets: cyclodextrins for oral cancer therapy.

  2012cites this paper
• Amphiphilic polymeric micelles as the nanocarrier for peroral delivery of poorly soluble anticancer drugs

  2012cites this paper
• Effects of formulation on pharmacokinetics of docetaxel in rats

  2012cites this paper
• Comparative pharmacokinetic study of paclitaxel and docetaxel in streptozotocin‐induced diabetic rats

  2012cites this paper
• RETRACTED ARTICLE: Dual approach utilizing self microemulsifying technique and novel P-gp inhibitor for effective delivery of taxanes

  2012cites this paper
• Development, Optimization and Absorption Mechanism of DHP107, Oral Paclitaxel Formulation for Single-Agent Anticancer Therapy

  2012cites this paper
• Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats.

  2012cites this paper
• Thermosensitive Self-Assembling Block Copolymers as Drug Delivery Systems

  2011cites this paper
• Drug Transporters and Their Role in Absorption and Disposition of Peptides and Peptide‐Based Pharmaceuticals

  2011cites this paper
• Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability

  2011cites this paper
• The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles.

  2011cites this paper
• Nanocápsulas policatiónicas: nuevos sistemas para la liberación intracelular de fármacos antitumorales

  2011cites this paper
• Development and in vivo evaluation of an oral drug delivery system for paclitaxel.

  2011cites this paper
• Nanoparticles for the Oral Administration of Cancer Therapies

  2011cites this paper
• Diverse approaches for the enhancement of oral drug bioavailability

  2011cites this paper
• PEO-PPO block copolymers for passive micellar targeting and overcoming multidrug resistance in cancer therapy.

  2011cites this paper
• The Promotive Effects of Antioxidative Apigenin on the Bioavailability of Paclitaxel for Oral Delivery in Rats

  2010cites this paper
• Effects of Silibinin, Inhibitor of CYP3A4 and P-Glycoprotein in vitro, on the Pharmacokinetics of Paclitaxel after Oral and Intravenous Administration in Rats

  2010cites this paper
• nhanced oral bioavailability of docetaxel in rats by four consecutive days of retreatment with curcumin

  2010cites this paper
• Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles.

  2010cites this paper
• Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies.

  2010cites this paper
• Curcumin enhances oral bioavailability and anti-tumor therapeutic efficacy of paclitaxel upon administration in nanoemulsion formulation.

  2010cites this paper
• A REVIEW ON TECHNIQUES FOR ORAL BIOAVAILABILITY ENHANCEMENT OF DRUGS

  2010cites this paper
• PBPK modeling of intestinal and liver enzymes and transporters in drug absorption and sequential metabolism.

  2010cites this paper
• Evaluation of the pharmacokinetic properties of new taxane derivatives

  2010cites this paper
• Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin.

  2010cites this paper